Technology | September 04, 2014

DynaMed to Utilize Information from the National Comprehensive Cancer Network

September 4, 2014 — Healthcare professionals will be able to access information about the latest and most complete oncology guidelines available at the point of care following an agreement between EBSCO Health and the National Comprehensive Cancer Network (NCCN). Information from NCCN will be summarized along with other evidence and guidelines in the content available from the clinical reference tool DynaMed.

NCCN, a not-for-profit alliance of 25 of the world's leading cancer centers, is dedicated to improving the quality, effectiveness and efficiency of cancer care. Through the leadership and expertise of clinical professionals at NCCN member institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the healthcare delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians and other healthcare decision-makers.

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) document evidence-based, consensus-driven management to ensure all patients receive preventive, diagnostic, treatment and supportive services that are most likely to lead to optimal outcomes. DynaMed will be able to use these guidelines as a reference to augment the existing evidence and guidelines that it considers when updating oncology topics. The DynaMed guidelines will include citations of the NCCN Content and will show the NCCN Categories of Evidence and Consensus.

DynaMed founder and vice president for evidence-based medicine research and development, quality and standards, Brian Alper, M.D., says the addition of the NCCN Guidelines as a clinical reference will enhance the currency of DynaMed’s oncology content. “Oncology is a field that changes very quickly and being able to utilize the NCCN Guidelines is a way to ensure the oncology content in DynaMed is the most current and comprehensive,” he said.

Several studies have shown DynaMed provides the most useful information to healthcare professionals at the point of care. DynaMed ranked highest among 10 online clinical resources in a study in the Journal of Clinical Epidemiology and twice was rated highest in its category by healthcare providers in a report on clinical decision support resources by KLAS.

For more information: www.health.ebsco.com/products/dynamed/clinical-decision-support

Related Content

Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

Pseudocolor accentuated CT scan image of a liver tumor. Image courtesy of Lucence Diagnostics.

News | Oncology Diagnostics | March 12, 2019
Genomic medicine company Lucence Diagnostics announced a new project to develop artificial intelligence (AI) algorithms...
Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease
News | Cardiac Imaging | February 11, 2019
The American College of Cardiology (ACC), along with nine other cardiology professional societies, recently published a...
IMS to Unveil Prototype Imaging Machine Learning Platform at HIMSS19
News | Artificial Intelligence | February 06, 2019
International Medical Solutions (IMS) announced a solution that will enable radiologists and other clinicians to use...
Siemens Healthineers Syngo.Breast Care Adding AI-Based Decision Support
News | Clinical Decision Support | February 05, 2019
Siemens Healthineers showcased the new planned artificial intelligence (AI)-based features with its mammography reading...
FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...
Infinitt Showcases New RIS/PACS Features at RSNA 2018
News | PACS | December 19, 2018
Infinitt North America highlighted a range of healthcare information technology (IT) products and applications at the...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.